100000 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink 100010 - Statement - Consolidated Balance Sheets link:presentationLink link:calculationLink link:definitionLink 100020 - Disclosure - Rewrite Acquisition - Summary of Transaction Price Determined and Allocated (Detail) 2 link:presentationLink link:calculationLink link:definitionLink 100030 - Statement - Consolidated Balance Sheets (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 100040 - Statement - Consolidated Statements of Operations and Comprehensive Loss link:presentationLink link:calculationLink link:definitionLink 100050 - Statement - Consolidated Statements of Operations and Comprehensive Loss (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 100060 - Statement - Consolidated Statements of Stockholders' Equity link:presentationLink link:calculationLink link:definitionLink 100070 - Statement - Consolidated Statements of Stockholders' Equity (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 100080 - Statement - Consolidated Statements of Cash Flows link:presentationLink link:calculationLink link:definitionLink 100090 - Statement - Consolidated Statements of Cash Flows (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 995455 - Disclosure - Nature of Operations link:presentationLink link:calculationLink link:definitionLink 995465 - Disclosure - Summary of Significant Accounting Policies link:presentationLink link:calculationLink link:definitionLink 995475 - Disclosure - Marketable Securities link:presentationLink link:calculationLink link:definitionLink 995485 - Disclosure - Fair Value Measurements link:presentationLink link:calculationLink link:definitionLink 995495 - Disclosure - Property and Equipment, Net link:presentationLink link:calculationLink link:definitionLink 995505 - Disclosure - Accrued Expenses link:presentationLink link:calculationLink link:definitionLink 995515 - Disclosure - Income Taxes link:presentationLink link:calculationLink link:definitionLink 995525 - Disclosure - Commitments and Contingencies link:presentationLink link:calculationLink link:definitionLink 995535 - Disclosure - Collaborations and Other Arrangements link:presentationLink link:calculationLink link:definitionLink 995545 - Disclosure - Equity-Method Investment and Other Investments link:presentationLink link:calculationLink link:definitionLink 995555 - Disclosure - Rewrite Acquisition link:presentationLink link:calculationLink link:definitionLink 995565 - Disclosure - Leases link:presentationLink link:calculationLink link:definitionLink 995575 - Disclosure - Stock-Based Compensation link:presentationLink link:calculationLink link:definitionLink 995585 - Disclosure - Loss Per Share link:presentationLink link:calculationLink link:definitionLink 995595 - Disclosure - Stockholders’ Equity link:presentationLink link:calculationLink link:definitionLink 995605 - Disclosure - Related Party Transactions link:presentationLink link:calculationLink link:definitionLink 995615 - Disclosure - 401(k) Plan link:presentationLink link:calculationLink link:definitionLink 995625 - Disclosure - Subsequent Event link:presentationLink link:calculationLink link:definitionLink 995635 - Disclosure - Summary of Significant Accounting Policies (Policies) link:presentationLink link:calculationLink link:definitionLink 995645 - Disclosure - Summary of Significant Accounting Policies (Tables) link:presentationLink link:calculationLink link:definitionLink 995655 - Disclosure - Marketable Securities (Tables) link:presentationLink link:calculationLink link:definitionLink 995665 - Disclosure - Fair Value Measurements (Tables) link:presentationLink link:calculationLink link:definitionLink 995675 - Disclosure - Property and Equipment, Net (Tables) link:presentationLink link:calculationLink link:definitionLink 995685 - Disclosure - Accrued Expenses (Tables) link:presentationLink link:calculationLink link:definitionLink 995695 - Disclosure - Income Taxes (Tables) link:presentationLink link:calculationLink link:definitionLink 995705 - Disclosure - Collaborations and Other Arrangements (Tables) link:presentationLink link:calculationLink link:definitionLink 995715 - Disclosure - Rewrite Acquisition (Tables) link:presentationLink link:calculationLink link:definitionLink 995725 - Disclosure - Leases (Tables) link:presentationLink link:calculationLink link:definitionLink 995735 - Disclosure - Stock-Based Compensation (Tables) link:presentationLink link:calculationLink link:definitionLink 995745 - Disclosure - Loss Per Share (Tables) link:presentationLink link:calculationLink link:definitionLink 995755 - Disclosure - Unaudited Quarterly Results (Tables) link:presentationLink link:calculationLink link:definitionLink 995765 - Disclosure - Nature of Operations - Additional Information (Detail) link:presentationLink link:calculationLink link:definitionLink 995775 - Disclosure - Summary of Significant Accounting Policies - Additional Information (Detail) link:presentationLink link:calculationLink link:definitionLink 995785 - Disclosure - Summary of Significant Accounting Policies - Summary of Property and Equipment at Cost and Recognizes Depreciation and Amortization Using the Straight-Line Method Over Estimated Useful Lives (Detail) link:presentationLink link:calculationLink link:definitionLink 995795 - Disclosure - Marketable Securities - Summary of Available -for-sale Marketable Securities (Detail) link:presentationLink link:calculationLink link:definitionLink 995805 - Disclosure - Marketable Securities - Additional Information (Detail) link:presentationLink link:calculationLink link:definitionLink 995815 - Disclosure - Fair Value Measurements - Summary of Financial Assets and Liabilities Recognized at Fair Value on Recurring Basis (Detail) link:presentationLink link:calculationLink link:definitionLink 995825 - Disclosure - Fair Value Measurements - Additional Information (Detail) link:presentationLink link:calculationLink link:definitionLink 995835 - Disclosure - Fair Value Measurements - Schedule of Change in Fair Value of the Contingent Consideration Liabilities (Detail) link:presentationLink link:calculationLink link:definitionLink 995845 - Disclosure - Property and Equipment, Net - Schedule of Property and Equipment (Detail) link:presentationLink link:calculationLink link:definitionLink 995855 - Disclosure - Property and Equipment, Net - Additional Information (Detail) link:presentationLink link:calculationLink link:definitionLink 995865 - Disclosure - Accrued Expenses - Schedule of Accrued Expenses (Detail) link:presentationLink link:calculationLink link:definitionLink 995875 - Disclosure - Income Taxes - Schedule of Reconciliation of the Federal Statutory Income Tax Rate and the Company's Effective Income Tax Rate (Detail) link:presentationLink link:calculationLink link:definitionLink 995885 - Disclosure - Income Taxes - Summary of Company's Net Deferred Tax Assets (Liabilities) (Detail) link:presentationLink link:calculationLink link:definitionLink 995895 - Disclosure - Income Taxes - Additional Information (Detail) link:presentationLink link:calculationLink link:definitionLink 995905 - Disclosure - Commitments and Contingencies - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 995915 - Disclosure - Leases - Schedule of Reconciliation of Undiscounted Cash Flows for Operating Lease Liabilities / Future Minimum Lease Payments (Detail)2 link:presentationLink link:calculationLink link:definitionLink 995925 - Disclosure - Collaborations and Other Arrangements - Summary of Changes in Accounts Receivable and Contract Liabilities (Detail) link:presentationLink link:calculationLink link:definitionLink 995935 - Disclosure - Collaborations and Other Arrangements- Summary of Revenues Recognized Resulting from Changes in Contract Liability Balance (Detail) link:presentationLink link:calculationLink link:definitionLink 995945 - Disclosure - Collaborations and Other Arrangements - Additional Information (Detail) link:presentationLink link:calculationLink link:definitionLink 995955 - Disclosure - Equity-Method Investment and Other Investments - Additional Information (Detail) link:presentationLink link:calculationLink link:definitionLink 995965 - Disclosure - Rewrite Acquisition - Additional Information (Detail) link:presentationLink link:calculationLink link:definitionLink 995975 - Disclosure - Rewrite Acquisition - Summary of Transaction Price Determined and Allocated (Detail) link:presentationLink link:calculationLink link:definitionLink 995985 - Disclosure - Leases - Additional Information (Detail) link:presentationLink link:calculationLink link:definitionLink 995995 - Disclosure - Leases - Summary of Lease Costs and Other Information (Detail) link:presentationLink link:calculationLink link:definitionLink 996005 - Disclosure - Leases - Schedule of Reconciliation of Undiscounted Cash Flows for Operating Lease Liabilities / Future Minimum Lease Payments (Detail) link:presentationLink link:calculationLink link:definitionLink 996015 - Disclosure - Stock-Based Compensation - Schedule of Equity-Based Compensation Expense (Detail) link:presentationLink link:calculationLink link:definitionLink 996025 - Disclosure - Stock-Based Compensation - Additional Information (Detail) link:presentationLink link:calculationLink link:definitionLink 996035 - Disclosure - Stock-Based Compensation - Summary of Restricted Stock Activity (Detail) link:presentationLink link:calculationLink link:definitionLink 996045 - Disclosure - Stock-Based Compensation - Summary of Weighted Average Assumptions Used to Compute Fair Value of Option Granted (Detail) link:presentationLink link:calculationLink link:definitionLink 996055 - Disclosure - Stock-Based Compensation - Summary of Stock Option Activity (Detail) link:presentationLink link:calculationLink link:definitionLink 996065 - Disclosure - Loss Per Share - Schedule of Basic and Diluted Net Loss Per Share (Detail) link:presentationLink link:calculationLink link:definitionLink 996075 - Disclosure - Loss Per Share - Potential Dilutive Securities Excluded from Computation of Diluted Net Loss Per Common Share (Detail) link:presentationLink link:calculationLink link:definitionLink 996085 - Disclosure - Stockholders' Equity - Additional Information (Detail) link:presentationLink link:calculationLink link:definitionLink 996095 - Disclosure - Related Party Transactions - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 996105 - Disclosure - 401(k) Plan - Additional Information (Detail) link:presentationLink link:calculationLink link:definitionLink Albany and Tudor Lease Albany And Tudor Lease [Member] Albany and Tudor Lease. Auditor Firm ID 2024 Lessee, Operating Lease, Liability, to be Paid, Year One Collaborative Arrangement and Arrangement Other than Collaborative [Domain] Collaborative Arrangement and Arrangement Other than Collaborative Document Transition Report Document Transition Report Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate Expected volatility of underlying stock Expected volatility Revenue from related party Revenue from Related Party Revenue from related party. Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term Weighted Average Remaining Contractual Term, Outstanding Total fair value amount, Vested Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value Amount Share based compensation arrangement by share based payment award equity instruments other than options vested in period weighted average grant date fair value amount. Deferred Tax Assets, in Process Research and Development Intangibles, including acquired in-process research and development Revenue, Remaining Performance Obligation, Amount Aggregate transaction price remaining to be recognized Accrued construction costs Accrued Construction Costs Accrued construction costs. Discount rate Discount rate Discount rate Brookline Street. Brookline Street [Member] 130 Brookline Street [Member] Prepaid lease payments Prepaid Lease Prepaid lease. Geographical [Axis] Geographical Accounting Standards Update 2014-09 [Member] ASU 2014-09 [Member] Rewrite merger agreement member. Rewrite Merger Agreement [Member] Rewrite Merger Agreement [Member] Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period Remaining vesting period Business combination transaction price. Business Combination Transaction Price Abstract Transaction Price Debt Securities, Available-for-Sale Estimated Fair Value Debt Securities, Available-for-sale, Total Increase (Decrease) in Prepaid Expense and Other Assets Prepaid expenses and other current assets Increase (Decrease) in Prepaid Expense and Other Assets, Total Unvested Restricted Stock Units [Member] Restricted Stock Units (RSUs) [Member] RSUs [Member] Other Assets [Member] Other Assets [Member] Fair Value, Inputs, Level 1 [Member] Level 1 [Member] Entity Public Float Entity Public Float 2027 Lessee, Operating Lease, Liability, to be Paid, Year Four Fair Value Disclosures [Text Block] Fair Value Measurements Deferred tax assets operating lease liability. Deferred Tax Assets Operating Lease Liability Operating lease liability Income Tax, Policy [Policy Text Block] Income Taxes Property, Plant and Equipment, Useful Life Estimated useful life Revenue from Contract with Customer, Excluding Assessed Tax Collaboration revenue Collaboration revenue Revenue from Contract with Customer, Excluding Assessed Tax, Total Contract with Customer, Liability, Change in Timeframe, Performance Obligation Satisfied, Revenue Recognized Deferred revenue, Deductions Proceeds From Sale of Marketable Securities Proceeds From Sale of Marketable Securities Proceeds from sale of marketable securities. Contra Revenue Contra Revenue Contra Revenue Payments to Acquire Businesses, Net of Cash Acquired, Total Payments to Acquire Businesses, Net of Cash Acquired Net of cash acquired Equity Method Investments and Joint Ventures [Abstract] ICFR Auditor Attestation Flag ICFR Auditor Attestation Flag Schedule of Business Acquisitions, by Acquisition [Table] Aggregate potential regulatory milestone payments available to be earned under a collaboration arrangement. Regulatory Based Milestone Payments Under Agreement Regulatory based milestone payments under agreement Current portion of deferred revenue ($0 and $19.9 million, respectively,from related party) Deferred revenue current Contract with Customer, Liability, Current Property Plant and Equipment Useful Life and Values [Abstract] Property Plant And Equipment Useful Life And Values [Abstract] Schedule of Changes in Fair Value of Plan Assets [Table Text Block] Schedule of Change in Fair Value of the Contingent Consideration Liabilities Stock-Based Compensation Compensation Related Costs, Policy [Policy Text Block] Title of Individual [Domain] Subsequent Event Subsequent Events [Text Block] Collaboration term extension period. Collaboration Term Extension Period Collaboration term extension period Operating Lease, Liability, Noncurrent Long-term operating lease liability Schedule of Stock by Class [Table] Schedule Of Stock By Class [Table] Investments, Fair Value Disclosure Marketable securities Investments, Fair Value Disclosure, Total Class of Stock [Line Items] Class Of Stock [Line Items] Income Tax Benefit [Table] Income Tax Benefit [Table] Income Tax Benefit [Table] Available-for-sales securities, noncurrent, maturing beyond year five. Available For Sales Securities Noncurrent Maturing Beyond Year Five Investments that matured beyond five years Related Party Transactions [Abstract] Balance Sheet Location [Axis] Balance Sheet Location Assets, Current Total current assets Vesting [Domain] Vesting Regeneron Agreement [Member] Regeneron Arrangement [Member] Regeneron arrangement. Liabilities and Equity Total Liabilities and Stockholders’ Equity Entity Address, State or Province Entity Address, State or Province Stock Issued During Period, Value, New Issues Issuance of common stock Issuance of common stock Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number Number of Options, Outstanding, Ending Balance Number of Options, Outstanding, Beginning Balance Stock options outstanding Cambridge [Member] Cambridge [Member] CambridgeMember Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value Weighted average grant date fair value per share Comprehensive loss Comprehensive Income (Loss), Net of Tax, Attributable to Parent Comprehensive loss Trading Symbol Trading Symbol Deferred Tax Assets, Net of Valuation Allowance Total deferred tax assets Common Stock, Shares, Issued Common stock, shares issued Common Stock, Shares, Issued, Total Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-Based Payment Arrangement, Percent Stock-based compensation Organization Consolidation And Presentation Of Financial Statements Disclosure [Table] Organization Consolidation And Presentation Of Financial Statements Disclosure [Table] Organization Consolidation And Presentation Of Financial Statements Disclosure [Table] Equity Method Investment, Amount Sold, Total Equity Method Investment, Amount Sold Deferral of equity method investment intra-entity profit on sales Number of tranches. Number Of Tranches Number of tranches Prepaid rent Prepaid Expense and Other Assets, Current Prepaid expenses and other current assets Albany Lease. Albany Lease [Member] Albany Lease [Member] Consolidated Entities [Domain] Equity Method of Accounting Equity Method Investments [Policy Text Block] Accounts Receivable, after Allowance for Credit Loss Accounts receivable Accounts Receivable, after Allowance for Credit Loss, Total Business combination upfront cash consideration. Business Combination Upfront Cash Consideration Upfront cash consideration 2026 Lessee, Operating Lease, Liability, to be Paid, Year Three Common Stock, Capital Shares Reserved for Future Issuance Shares available for future issuance Investments and other assets, related party Investments and Other Assets from Related Parties Current Investments and other assets from related parties current. AOCI Attributable to Parent [Member] Accumulated Other Comprehensive Income Business Combination Disclosure [Text Block] Rewrite Acquisition Business combination research contingent consideration liabilities. Business Combination Research Contingent Consideration Liabilities Research contingent consideration liabilities Deferred Tax Liabilities, Property, Plant and Equipment Fixed assets Entity Address, City or Town Entity Address, City or Town Related Party Transaction [Line Items] Newco Member NewCo [Member] NewCo [Member] Operating Lease, Weighted Average Discount Rate, Percent Weighted average discount rate Operating Loss Carryforward Indefinitely Begins to Expire in 2034 [Member] Operating Loss Carryforward Indefinitely Begins To Expire In Two Thousand Thirty Four [Member] Operating Loss Carryforward Indefinitely Begins to Expire in 2034 [Member] Lessee, Operating Lease, Renewal Term Operating lease, renewal term Property, Plant and Equipment [Table Text Block] Schedule of Property and Equipment Preferred Stock Purchase Agreement [Member] Preferred Stock Purchase Agreement [Member] Deferred Tax Assets, Operating Loss Carryforwards, Subject to Expiration Net operating loss carryforwards, with expiration date Performance based stock options. Performance Based Stock Options [Member] Performance Based Stock Options [Member] Subsequent Event [Member] Subsequent Event Type [Axis] Additional Paid-in Capital [Member] Additional Paid-In Capital Estimated useful life Property, Plant, and Equipment, Useful Life, Term, Description [Extensible Enumeration] Measurement Input, Discount for Lack of Marketability [Member] Series B Preferred Stock [Member] Liabilities, Current [Abstract] Current Liabilities: Assets, Current [Abstract] Current Assets: Counterparty Name [Axis] Counterparty Name Pre-specified research milestones. Prespecified Research Milestones Member Pre-specified Research Milestones [Member] Statement of Stockholders' Equity [Abstract] Operating Lease, Liability, Current Current portion of operating lease liability Marketable Securities, Policy [Policy Text Block] Marketable Securities Revenue Revenue from Contract with Customer, Including Assessed Tax Increase in accounts receivables. Increase In Accounts Receivables Accounts receivable, Additions Property, Plant and Equipment, Net Property and equipment, net Property and equipment, net Property, Plant and Equipment, Net, Beginning Balance Property, Plant and Equipment, Net, Ending Balance Class of Stock [Domain] Contingent Consideration Classified as Equity, Fair Value Disclosure Change in fair value Investment Income, Interest Interest income Restricted cash equivalents, included in investments and other assets Restricted Cash Equivalents Restricted cash equivalents Restricted Cash Equivalents, Total Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent Federal statutory income tax rate Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Collaborative Arrangement and Arrangement Other than Collaborative Entity Central Index Key Entity Central Index Key Deferred Tax Asset, Tax Deferred Expense, Reserve and Accrual, Accounts Receivable, Allowance for Credit Loss Accruals and allowances Operating lease right-of-use assets Increase (decrease) in operating right of use assets. Increase Decrease In Operating Right Of Use Assets Increase in operating lease right-of-use assets Plan Name [Domain] Plan Name Proceeds from at-the-market offerings unpaid at period end Proceeds From At-The-Market Offerings Unpaid At Period End Proceeds from at-the-market offerings unpaid at period end. Related Party [Member] Related Party [Member] Collaboration agreement further option extension period. Collaboration Agreement Further Option Extension Period Collaboration agreement further option extension period AvencellCoCo AvencellCoCo[Member] Avencell CoCo member. Total Assets, Fair Value Disclosure, Total Assets, Fair Value Disclosure Increase (Decrease) in Other Operating Assets Other assets Increase (Decrease) in Other Operating Assets, Total Lessee, Operating Lease, Option to Extend Operating lease, options to extend Payment of contingent consideration Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements 2020 Regeneron Amendment [Member] Two Thousand And Twenty Regeneron Amendment [Member] Two thousand and twenty regeneron amendment. Aggregate potential sales-based milestone payments available to be earned under a collaboration arrangement. Sales Based Milestone Payments Under Agreement Sales based milestone payments under agreement Liabilities, Current Total current liabilities Entity Tax Identification Number Entity Tax Identification Number Net operating loss carryover, percentage of taxable income. Net Operating Loss Carryover Percentage Of Taxable Income Net operating loss carryover, percentage of taxable income Deferred tax liabilities operating lease right of use assets. Deferred Tax Liabilities Operating Lease Right Of Use Assets Operating lease right-of-use assets Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Table] Increase (Decrease) in Operating Capital [Abstract] Changes in operating assets and liabilities: Equity investment adjustments Deferred Tax Assets, Equity Method Investments Financial Instruments [Domain] Financial Instruments Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-Based Compensation Cost Equity-based compensation Investment, Name [Axis] Stock Issued During Period, Value, Employee Stock Purchase Plan Issuance of shares under employee stock purchase plan Lessee, Operating Leases [Text Block] Leases Lessee, Operating Lease, Lease Not yet Commenced, Existence of Option to Extend [true false] Operating lease, existence of option to extend Restricted Stock [Member] Restricted Stock [Member] Plan Name [Axis] Plan Name Contract with customer liability additions. Contract With Customer Liability Additions Deferred revenue additions Payment related to leaseback Geographical [Domain] Geographical Lease term Lessee, Operating Lease, Term of Contract Operating lease, term of contract Assets Total Assets Percentage of premium over volume-weighted average trading price of common stock during 30-day period prior to closing of equity transaction. Percentage Of Premium Over Volume Weighted Average Trading Price Of Common Stock During30 Day Period Prior To Closing Of Equity Transaction Percentage of premium over volume-weighted average trading price of common stock during 30-day period prior to closing of equity transaction Operating Lease, Right-of-Use Asset Operating lease right-of-use assets Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount Unrecognized compensation cost related to stock options Entity Registrant Name Entity Registrant Name Asset-Backed Securities [Member] Other Asset Backed Securities [Member] Executive Officer [Member] Senior Executives [Member] Lessee, Operating Lease, Existence of Option to Extend [true false] Operating lease, existence of option to extend Upfront consideration payable in cash Upfront Consideration Payable In Cash Upfront consideration payable in cash Lessee, Lease, Description [Line Items] Lessee Lease Description [Line Items] Related Party, Type [Domain] Non-Marketable Equity Securities Non - Marketable Equity Securities , Policy [Policy Text Block] Disclosure of accounting policy for investment classified as non-marketable equity securities. Retained Earnings (Accumulated Deficit) Accumulated deficit Retained Earnings (Accumulated Deficit), Total Retained Earnings (Accumulated Deficit), Beginning Balance Retained Earnings (Accumulated Deficit), Ending Balance Proceeds from Stock Plans Issuance of shares through employee stock purchase plan Supplemental Cash Flow Information [Abstract] SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION: Retained Earnings [Member] Retained Earnings Class of Stock [Axis] Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number Number of Shares, Unvested, Ending balance Number of Shares, Unvested, Beginning balance Number of unique ex vivo products commercialized. Number Of Unique Ex Vivo Products Commercialized Number of unique ex vivo products commercialized Stock Issued During Period, Shares, Employee Stock Purchase Plans Issuance of shares under employee stock purchase plan, shares Minimum [Member] Minimum [Member] Equity securities measurement input, percentage Equity securities Fv Ni measurement input, percentage. Equity Securities Fv Ni Measurement Input, Percentage Proceeds from Stock Options Exercised Proceeds from options exercised Significant Accounting Policies [Text Block] Summary of Significant Accounting Policies Total operating lease liabilities at December 31, 2023 Operating Lease, Liability Operating Lease, Liability, Total Right-of-use assets acquired under operating lease. Right Of Use Assets Acquired Under Operating Lease Right-of-use assets acquired under operating leases Share-Based Payment Arrangement, Tranche One [Member] First Anniversary of Original Vesting Date [Member] Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum Expected volatility of underlying stock, Minimum Equity Component [Domain] Equity Component Tax Carryforwards Begin to Expire in 2034 [Member] Tax Credit Carryforwards Begin To Expire In Two Thousand Thirty Four [Member] Tax Carryforwards Begin to Expire in 2034 [Member] Office furniture and equipment. Office Furniture And Equipment [Member] Office Furniture and Equipment [Member] Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Adjustments to reconcile net loss to net cash used in operating activities: Measurement Frequency [Axis] Measurement Frequency Sublease income Sublease income Sublease Income Stock purchase agreement date. Stock Purchase Agreement Date Stock purchase agreement date Marketable Securities [Abstract] Marketable securities: Entity Current Reporting Status Entity Current Reporting Status Common Stock, Shares Authorized Common stock, shares authorized Research and Development Expense Research and development Research and Development Expense, Total Financial institution debt securities. Financial Institution Debt Securities [Member] Financial Institution Debt Securities [Member] Deferred Tax Liabilities, Gross Total deferred tax liabilities Deferred Tax Liabilities, Gross, Total Proceeds from Issuance of Convertible Preferred Stock Proceeds from issuance of convertible preferred stock Assets [Abstract] ASSETS Aggregate potential clinical development milestone payments available to be earned under a collaboration arrangement for each available target selected by the collaborator. Development Based Milestone Payments Under Agreement Milestone payments Net proceeds from issuance of common stock Proceeds from Issuance of Common Stock Proceeds from common stock offering Revenue from Contract with Customer [Policy Text Block] Revenue Recognition Accounts Receivable, after Allowance for Credit Loss [Abstract] Accounts receivable: Accrued research and development expenses current. Accrued Research And Development Expenses Current Accrued research and development Performance based restricted stock units. Performance Based Restricted Stock Units [Member] Performance Based RSUs [Member] Common stock, $0.0001 par value; 240,000,000 and 120,000,000 shares authorized at December 31, 2023 and December 31, 2022, respectively;92,997,158 and 87,103,007 shares issued and outstanding at December 31, 2023 and December 31, 2022, respectively Common Stock, Value, Issued Common Stock, Value, Issued, Total Common Stock, Value, Issued, Beginning Balance Common Stock, Value, Issued, Ending Balance Lessee, Operating Sublease, Existence of Option to Extend [true false] Operating sublease, existence of option to extend Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent Change in valuation allowance Hemophilia Co/Co agreements. Hemophilia Co Co Agreements [Member] Hemophilia Co Co Agreements Proceeds from Sale of Property, Plant, and Equipment Proceeds from sale of property and equipment Proceeds from Sale of Property, Plant, and Equipment, Total Legal, accounting and other fees. Legal Accounting And Other Fees Legal accounting and other fees Lessee, Operating Lease, Lease Not yet Commenced, Description Operating lease, description Non-cash trade-in of property and equipment Non-cash trade-in of property and equipment. Non-cash Trade-in Of Property and Equipment Contract with Customer, Liability, Revenue Recognized Amounts included in the contract liability at the beginning of the period Accrued expenses ($1.0 million and $1.6 million, respectively, from related party) Accrued Liabilities, Current Total accrued expenses Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents Cash acquired Current Fiscal Year End Date Current Fiscal Year End Date Stock-based compensation Share-Based Payment Arrangement, Noncash Expense Share-based Payment Arrangement, Noncash Expense, Total Deferred tax assets, tax credit carryforwards, expiration description. Deferred Tax Assets Tax Credit Carryforwards Expiration Description Tax credit carryforwards, expiration date description Auditor Name Organization consolidation and presentation of financial statements disclosure. Organization Consolidation And Presentation Of Financial Statements Disclosure [Line Items] Organization Consolidation And Presentation Of Financial Statements Disclosure [Line Items] Operating Income (Loss) Operating loss Business Acquisition, Equity Interest Issued or Issuable, Number of Shares Common stock, shares issued in connection with research milestone Novartis Institutes for BioMedical Research Inc. Novartis Institutes For Bio Medical Research Inc [Member] Novartis [Member] Business Combination, Consideration Transferred Total transaction price Business Combination Consideration Transferred 1 Contingent consideration Asset Acquisition, Contingent Consideration, Liability, Total Asset Acquisition, Contingent Consideration, Liability Contingent consideration liability assumed in asset acquisition New CAR T-Cell Therapy [Member] New C A R T Cell Therapy [Member] New car t-cell therapy. Marketable Securities [Line Items] Marketable Securities [Line Items] Lessee, Operating Lease, Lease Not yet Commenced, Option to Extend Operating lease, options to extend Research and Development Expense [Member] Research and Development [Member] Contingent consideration paid Contingent Consideration Paid to Rewrite Holders Contingent consideration paid to rewrite holders. Nature of Operations Nature of Operations [Text Block] Vesting restricted stock units. Vesting Restricted Stock Units Vesting of restricted stock units Cash Cash Cash, Ending Balance Cash, Beginning Balance Accounts Payable and Accrued Liabilities Disclosure [Text Block] Accrued Expenses Share-Based Payment Arrangement, Expense Equity-based compensation expense Acceleration resulted in additional expense Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum Expected volatility of underlying stock, Maximum Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage Vest percentage on the first anniversary Measurement Input Type [Domain] Extension fee Contract With Customer Liability Extension Fee Contract With Customer Liability Extension Fee Marketable Securities [Table] Marketable Securities [Table] Accounting Standards Update 2016-02 [Member] ASC 842 [Member] Liability for milestone payment. Liability For Milestone Payment Liability for milestone payment Operating loss carryforward indefinitely. Operating Loss Carryforward Indefinitely [Member] Operating Loss Carryforward Indefinitely [Member] Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block] Impairment of Long-Lived Assets Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value Aggregate Intrinsic Value, Outstanding Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents [Abstract] Reconciliation of cash, cash equivalents and restricted cash equivalents to consolidated balance sheet: Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table] Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Table] Earnings Per Share, Policy [Policy Text Block] (Loss) Earnings per Share Cumulative Effect, Period of Adoption, Adjustment [Member] Cumulative Effect, Period of Adoption, Adjustment [Member] Business combination transaction price allocated. Business Combination Transaction Price Allocated Abstract Transaction Price Allocated Research and development services. Research And Development Services [Member] Research and Development Services [Member] Stock-based compensation, shares Stock issued during period shares share-based compensation expense. Stock Issued During Period Shares Sharebased Compensation Expense Total other income (expense), net Other Nonoperating Income (Expense) Sale of Stock, Price Per Share Sale of stock, price per share Business Combination, Contingent Consideration, Liability, Noncurrent Contingent consideration liability Property, Plant and Equipment [Abstract] NewCo Co/Co Agreement [Member] NewCo Co/Co Agreement [Member] Laboratory equipment. Laboratory Equipment [Member] Laboratory Equipment [Member] Revenue from contract with customer. Revenue From Contract With Customer Table [Text Block] Summary of Revenues Recognized Resulting From Changes in Contract Liability Balance AvenCell Co/Co Agreement [Member] AvenCell Co Co Agreement [Member] AvenCell Co Co agreement. Entity Voluntary Filers Entity Voluntary Filers Subsequent Events [Abstract] Transaction price. Transaction Price Transaction price Commitments and Contingencies Disclosure [Abstract] Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross Number of options, Granted Other Accrued Liabilities, Current Accrued other Equity [Text Block] Stockholders’ Equity Share-Based Compensation Arrangement by Share-Based Payment Award, Description Description of stock options granted under the Plan Deferred Tax Assets, Operating Loss Carryforwards, Not Subject to Expiration Net operating loss carryforwards with no expiration date Retirement Plan Type [Domain] Retirement Plan Type Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax Gross Unrealized Gains Equity, Attributable to Parent [Abstract] Stockholders’ Equity: Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Investment Owned, Fair Value Investment Owned, Fair Value Investment Owned, at Fair Value, Beginning Balance Investment Owned, at Fair Value, Ending Balance Lessee, Operating Lease, Liability, to be Paid, after Year Five Thereafter Lease, Cost [Table Text Block] Summary of Lease Costs and Other Information Loss (gain) on disposal of property and equipment Gain (Loss) on Disposition of Property Plant Equipment Gain (Loss) on Disposition of Property Plant Equipment, Total Earnings Per Share [Abstract] Other comprehensive loss - unrealized gain (loss) on marketable securities OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax, Total Investment, Name [Domain] Accounting Policies [Abstract] Sparing Vision SAS [Member] Sparing Vision [Member] Sparing Vision [Member] Lessee, Lease, Description [Table] Lessee Lease Description [Table] Lessee, Operating Lease, Description [Abstract] Other information Operating loss carryforward begin to Expire in 2034. Operating Loss Carryforward Begin To Expire In Two Thousand Thirty Four [Member] Operating Loss Carryforward Begin to Expire In 2034 [Member] Concentration Risk, Credit Risk, Policy [Policy Text Block] Concentrations of Credit Risk Sale of Stock, Consideration Received on Transaction Cash consideration received on sale of common stock Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Two thousand twenty two sales agreement. Two Thousand Twenty Two Sales Agreement [Member] 2022 Sales Agreement [Member] Increase (decrease) in operating lease liabilities. Increase Decrease In Operating Lease Liabilities Operating lease liabilities Lessee, Operating Lease, Lease Not yet Commenced, Term of Contract Term of lease Winter street lease member. Winter Street Lease [Member] 840 Winter Street Lease [Member] Payments for rent Payments for Rent Increase in deferred tax assets valuation allowance. Increase In Deferred Tax Assets Valuation Allowance Increase in valuation allowance Earnings Per Share, Basic, Total Earnings Per Share, Basic Earnings Per Share, Basic Net Loss Per Share, Basic Amortization of costs for tax purpose description Significant Change in Unrecognized Tax Benefits is Reasonably Possible, Other Information Commitments and Contingencies Commitments and contingencies (Note 8) Business Combinations [Abstract] Income Statement [Abstract] Property, Plant and Equipment Disclosure [Text Block] Property and Equipment, Net Related Party, Type [Axis] Operating Lease, Cost Operating lease cost Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability Change in fair value of contingent consideration Change in fair value of contingent consideration Business combination transaction price. Business Combination Transaction Price Total transaction price Tenant improvement allowance per rentable square foot Tenant Improvement Allowance Per Rentable Square Foot Tenant improvement allowance per rentable square foot. Retirement Benefits [Abstract] Measurement Input Type [Axis] Statistical Measurement [Domain] Statistical Measurement Net Cash Provided by (Used in) Operating Activities Net cash used in operating activities crispr Product. C R I S P R Product [Member] CRISPR Product [Member] Document Period End Date Document Period End Date Statistical Measurement [Axis] Statistical Measurement Commitments and Contingencies Disclosure [Text Block] Commitments and Contingencies Operating Lease, Payments Operating cash flows used for operating leases Earnings Per Share, Diluted, Total Earnings Per Share, Diluted Net loss per share, basic and diluted Net Loss Per Share, Diluted Share based compensation arrangement by share based payment award equity instruments other than options cancelled in period. Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Cancelled In Period Number of shares, cancelled Number of Shares, Cancelled Product and Service [Domain] Product and Service Deferred Tax Assets, Operating Loss Carryforwards, Domestic Net operating loss carryforwards, federal Lease, Cost [Abstract] Lease cost Deferred Tax Assets, Operating Loss Carryforwards Net operating loss carryforwards Deferred Tax Assets, Operating Loss Carryforwards, Total Unrecognized Tax Benefits Unrecognized tax benefits Unrecognized Tax Benefits, Beginning Balance Unrecognized Tax Benefits, Ending Balance Regulatory approval milestone. Regulatory Approval Milestone Member Regulatory Approval Milestone [Member] Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent Research and development tax credits Revenue from Contract with Customer [Abstract] 2024 Technology Collaboration Extension [Member] Two Thousand Twenty Four Technology Collaboration Extension [Member] Two thousand twenty four technology collaboration extension. Fair Value Hierarchy and NAV [Domain] Fair Value Hierarchy and NAV Contract with Customer, Liability, Cumulative Catch-up Adjustment to Revenue, Change in Measure of Progress Deferred revenue, Additions Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number Number of Options, Exercisable Business acquisition cost of acquired entity transaction cost. Business Acquisition Cost Of Acquired Entity Transaction Cost Transaction costs Fair Value, Recurring [Member] Fair Value on Recurring Basis [Member] Number of Reportable Segments Number of reportable segment Additional Paid in Capital, Common Stock Additional paid-in capital Additional Paid in Capital, Common Stock, Beginning Balance Additional Paid in Capital, Common Stock, Ending Balance Investment in Kyverna Therapeutics, Inc. Payments for Purchase of Investments Payments for purchase of investments. Deferred Tax Assets, Net Net deferred tax asset (liability) Defined Contribution Plan Disclosure [Line Items] Defined Contribution Plan Disclosure [Line Items] Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay Employer matching contribution of employee contribution, percent Lessee operating lease expiration month year (YYYY-MM). Lessee Operating Lease Expiration Month Year Operating lease expiration Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period Exercise of stock options, shares Number of options, Exercised Liabilities and Equity [Abstract] LIABILITIES AND STOCKHOLDERS’ EQUITY Follow-on public offering. Follow On Public Offering [Member] Follow On Public Offering Follow-on public Offerings [Member] Measurement Input, Option Volatility [Member] Entity Address, Postal Zip Code Entity Address, Postal Zip Code Entity Interactive Data Current Entity Interactive Data Current Defined Contribution Plan, Employer Matching Contribution, Percent of Match Employer matching contribution, percent Increase (Decrease) in Accounts Payable Accounts payable Increase (Decrease) in Accounts Payable, Total Type of Revenue [Extensible List] Revenue, Product and Service [Extensible Enumeration] Equity [Abstract] Lessee, Operating Lease, Liability, Undiscounted Excess Amount Less: imputed interest Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period Number of Shares, Granted Number of Shares, Granted Payments to Acquire in Process Research and Development Acquired in-process research and development, net of cash acquired of $287 Entity Well-known Seasoned Issuer Entity Well-known Seasoned Issuer Payroll Deductions Eligible Compensation Percent Payroll deductions eligible compensation percent. Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Abstract] Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price Weighted Average Exercise Price per Share, Exercised Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Business combination, recognized identifiable assets acquired and liabilities assumed, In-process research and development. Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed In Process Research And Development In-process research and development Cash and Cash Equivalents, Policy [Policy Text Block] Cash Equivalents Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest [Abstract] Other comprehensive loss: Equity Components [Axis] Equity Components Increase (Decrease) in Accounts Receivable Accounts receivable Investments, Debt and Equity Securities [Abstract] Retirement Benefits [Text Block] 401(k) Plan Accrued expenses, related party Other Receivables, Net, Current Other Receivables, Net, Current, Total Schedule of Equity Method Investments [Table] Second CoDevelopment and CoPromotion Agreement [Member] Second CoDevelopment And CoPromotion Agreements [Member] Second CoDevelopment And CoPromotion Agreements [Member] Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value Weighted Average Grant Date Fair Value per Share, Vested Local Phone Number Local Phone Number Amount allocated to licenses to targets and associated research activities and evaluation plans. Amount Allocated To Licenses To Targets And Associated Research Activities And Evaluation Plans Amount allocated to licenses to targets and associated research activities and evaluation plans Property, Plant and Equipment [Line Items] Property, Plant and Equipment [Line Items] Sale of Stock [Axis] Sale of Stock Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price Weighted Average Exercise Price per Share, Exercisable Additional tenant improvement allowance per rentable square foot Additional tenant improvement allowance per rentable square foot Defined Contribution Plan [Table] Defined Contribution Plan [Table] Schedule of Equity Method Investments [Line Items] Summary of significant accounting policies. Summary Of Significant Accounting Policies [Line Items] Summary Of Significant Accounting Policies [Line Items] Statement of Cash Flows [Abstract] Contingent consideration paid, shares Contingent Consideration Shares Paid to Rewrite Holders Contingent consideration shares paid to rewrite holders Income Tax Authority [Domain] Income Tax Authority Organization, Consolidation and Presentation of Financial Statements [Abstract] Accumulated other comprehensive loss Accumulated Other Comprehensive Income (Loss), Net of Tax Accumulated Other Comprehensive Income (Loss), Net of Tax, Total Property, Plant and Equipment, Policy [Policy Text Block] Property and Equipment Document Annual Report Document Annual Report Common Stock, Par or Stated Value Per Share Common stock, par value Cumulative Effect, Period of Adoption [Axis] Cumulative Effect, Period of Adoption Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition Weighted average period of unrecognized compensation costs Long-Lived Tangible Asset [Axis] Long-Lived Tangible Asset Number of remaining shares eligible for sale under agreement value. Number Of Remaining Shares Eligible For Sale Under Agreement Value Proceeds from common stock offering Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table] Collaborative Arrangement Disclosure [Text Block] Collaborations and Other Arrangements Maximum [Member] Maximum [Member] Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights Vesting description Proceeds from Issuance of Private Placement Purchase of common stock through private placement Available-for-sales securities, non-current, maturity period. Available For Sales Securities Non Current Maturity Period Available-for-sales Securities, non-current, maturity period Memorial drive 640 member Memorial Drive 640 [Member] 640 Memorial Drive [member[ Percentage of gross proceeds from common stock as sales agent cash commission. Percentage Of Gross Proceeds From Common Stock As Sales Agent Cash Commission Percentage of gross proceeds from common stock as sales agent cash commission Commitments And Contingencies [Table] Commitments And Contingencies [Table] Commitments and contingencies. Fair Value, Inputs, Level 3 [Member] Level 3 [Member] Stock-based compensation APIC, Share-Based Payment Arrangement, Increase for Cost Recognition APIC, Share-based Payment Arrangement, Increase for Cost Recognition, Total Fair Value, Recurring and Nonrecurring [Table] Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Table] Net (decrease) increase in cash and cash equivalents and restricted cash equivalents Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Payables and Accruals [Abstract] Satisfaction Of a Service Condition Satisfaction Of a Service Condition [Member] Satisfaction of a service condition [Member] Other comprehensive gain (loss) from equity method investment Other comprehensive loss - equity method investment Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI for Investment Transferred from Available-for-Sale to Equity Method, Tax General and Administrative Expense [Member] General and Administrative [Member] General and Administrative Expenses [Member] Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period Performance-based options forfeited Number of options, Forfeited Document Financial Statement Error Correction [Flag] Document Financial Statement Error Correction [Flag] Section 174 capitalized research Deferred Tax Assets Capitalized Research Deferred tax assets capitalized research. Co-Development And Co-Funding Agreement Member. Co-Development And Co-Funding Agreement [Member] Co-development and co-funding agreement member Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block] Potential Dilutive Securities Excluded from Computation of Diluted Net Loss Per Common Share City Area Code City Area Code Research and Development Arrangement, Contract to Perform for Others, Type [Axis] Research and Development Arrangement, Contract to Perform for Others, Type Net Cash Provided by (Used in) Operating Activities [Abstract] CASH FLOWS FROM OPERATING ACTIVITIES: Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block] Marketable Securities Vesting of restricted stock units, shares Stock Issued During Period Shares Vesting Restricted Units Stock issued during period shares vesting restricted units. Income tax benefit. Income Tax Benefit [Line Items] Income Tax Benefit [Line Items] Quarterly Financial Information [Table Text Block] Schedule of Results of Operations on Quarterly Basis U S Treasury And Other Government Backed Securities [Member] U S Treasury And Other Government Backed Securities [Member] U S Treasury and other government backed securities. Business Acquisition [Line Items] Fair value of stock received Sale of Stock, Consideration Received Per Transaction Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Less: accumulated depreciation and amortization Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Total Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Beginning Balance Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Ending Balance General and Administrative Expense General and administrative General and Administrative Expense, Total Waltham Lease [Member] Waltham lease. Waltham Lease [Member] Lessee operating lease extended expiration date. Lessee Operating Lease Extended Expiration Date Lessee operating lease extended expiration date Weighted Average Number of Shares Outstanding, Basic, Total Weighted Average Number of Shares Outstanding, Basic Weighted average shares outstanding, basic Research and Development Arrangement, Contract to Perform for Others, Type [Domain] Research and Development Arrangement, Contract to Perform for Others, Type Net Cash Provided by (Used in) Financing Activities [Abstract] CASH FLOWS FROM FINANCING ACTIVITIES: Research and Development Expense, Policy [Policy Text Block] Research and Development Expenses Lessee, Operating Lease, Description Operating lease, description Share-Based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block] Summary of Restricted Stock Activity Statement [Table] Statement [Table] Share-Based Payment Arrangement, Option, Activity [Table Text Block] Summary of Stock Option Activity Schedule of Related Party Transactions, by Related Party [Table] Contingent Consideration Type [Domain] Summary of Weighted Average Assumptions Used to Compute Fair Value of Option Granted Under 2016 Plan to Employees Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block] Summary of Weighted Average Assumptions Used to Compute Fair Value of Option Granted Increase (Decrease) in Contract with Customer, Liability Deferred revenue Document Fiscal Period Focus Document Fiscal Period Focus Lessee, Operating Lease, Liability, to be Paid Total lease payments Loss from equity method investments Income (Loss) from Equity Method Investments Income (Loss) from Equity Method Investments, Total Loss from equity method investment Related Party Transactions Disclosure [Text Block] Related Party Transactions Measurement input option subsequent financing. Measurement Input Option Subsequent Financing [Member] 2025 Lessee, Operating Lease, Liability, to be Paid, Year Two Accrued Professional Fees, Current Accrued legal and professional expenses Statement [Line Items] Statement [Line Items] Cumulative catch up adjustment. Cumulative Catch Up Adjustment Cumulative catch up adjustment Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Potential dilutive securities excluded from computation of diluted net loss per common share Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value Balance Balance Deferred tax assets tax credit carryforwards begin to expire year. Deferred Tax Assets Tax Credit Carryforwards Begin To Expire Year Tax credit carryforwards, begins to expiring year Software and Software Development Costs [Member] Computer Software [Member] Net lease cost Lease, Cost Period for which the taxable income available from the loss was generated. Period For Which Taxable Income Available From Loss Was Generated Taxable Income available for the period the loss was generated Schedule of Deferred Tax Assets and Liabilities [Table Text Block] Summary of Company's Net Deferred Tax Assets (Liabilities) Accounts receivable, related party Accounts receivable ($0.2 million and $0.3 million, respectively,from related party) Accounts Receivable, after Allowance for Credit Loss, Current Accounts receivable, Balance at End of Period Accounts receivable, Balance at Beginning of Period Accounts Receivable, after Allowance for Credit Loss, Current, Total Deferred tax assets operating loss carryforwards begins to expire year. Deferred Tax Assets Operating Loss Carryforwards Begins To Expire Year Net operating loss carryforwards, begins to expiring year Cumulative Effect, Period of Adoption [Domain] Cumulative Effect, Period of Adoption Materials Shipped [Member] Materials Shipped [Member] Materials Shipped Underwriting Agreement [Member] Underwriting Agreements [Member] Underwriting agreements. Common Stock Common Stock [Member] Cash and Cash Equivalents, at Carrying Value Cash and cash equivalents Cash and Cash Equivalents, at Carrying Value, Total Cash and Cash Equivalents, at Carrying Value, Beginning Balance Cash and Cash Equivalents, at Carrying Value, Ending Balance Second amendment. Second Amendment [Member] Second Amendment [Member] Schedule of Stock-Based Compensation Expense Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block] Deferred tax assets tax credit carryforwards research expiration year. Deferred Tax Assets Tax Credit Carryforwards Research Expiration Year Research and development tax credits, expiration year Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value Aggregate Intrinsic Value, Exercisable (Accretion) amortization of investment discounts and premiums Accretion (Amortization) of Discounts and Premiums, Investments Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Current portion of deferred revenue, related party Contract with customer liability, related party, current. Contract with Customer Liability, Related Party, Current Antidilutive Securities, Name [Domain] Antidilutive Securities, Name Variable Interest Entity Consolidation, Variable Interest Entity, Policy [Policy Text Block] Tudor Lease Member Tudor Lease [Member] Tudor Lease. Cash [Member] Cash [Member] Cover Cover [Abstract] Lessee operating lease terminate term. Lessee Operating Lease Terminate Term Operating lease, terminate term Vesting [Axis] Vesting Document Fiscal Year Focus Document Fiscal Year Focus At-the-market offerings. At The Market Offerings [Member] At The Market Offerings At The Market Offerings [Member] Transaction price allocated to combined performance obligation. Transaction Price Allocated To Combined Performance Obligation Transaction price allocated to combined performance obligation KyvernaLca KyvernaLca [Member] KyvernaLca member. Erie Street. Erie Street [Member] 40 Erie Street [Member] Marketable Securities, Realized Gain (Loss) Realized gains or losses on marketable securities Marketable Securities, Realized Gain (Loss), Total 2016 Regeneron Agreement [Member] Two Thousand Sixteen Regeneron Agreement [Member] Two thousand sixteen Regeneron Agreement. Summary Of Significant Accounting Policies [Table] Summary Of Significant Accounting Policies [Table] Summary Of Significant Accounting Policies [Table] Sale of Stock [Domain] Sale of Stock Joint venture avencell. Joint Venture AvenCell [Member] Joint Venture AvenCell [Member] Stock Purchase Agreement [Member] Stock Purchase Agreement [Member] Stock purchase agreement. Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value Weighted Average Grant Date Fair Value per Share, Granted Changes in accounts receivable and contract liabilities. Changes In Accounts Receivable And Contract Liabilities Table [Text Block] Summary of Changes in Accounts Receivable and Contract Liabilities Security Exchange Name Security Exchange Name Payments due from affiliates. Payments Due From Affiliates Payments due Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period Maximum term of stock options granted Compensation Related Costs [Abstract] Domestic Tax Authority [Member] Federal [Member] Other comprehensive loss - equity method investment Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent, Total New Accounting Pronouncements, Policy [Policy Text Block] Recent Accounting Pronouncements SubLease Agreement [Member] SubLease agreement. Property, Plant and Equipment, Gross Total property and equipment Property, Plant and Equipment, Gross, Total Property, Plant and Equipment, Gross, Beginning Balance Property, Plant and Equipment, Gross, Ending Balance Rewrite Therapeutics Delaware Corporation [Member] Rewrite therapeutics telaware corporation [Member] Rewrite Therapeutics Delaware Corporation [Member] AvencellLca AvencellLca [Member] Avencell lca member. Right-of-Use Asset Obtained in Exchange for Operating Lease Liability Operating lease liabilities arising from obtaining right-of-use assets AvenCell Therapeutics, Inc [Member] AvenCell Member AvenCell [Member] AvenCell Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price Weighted Average Exercise Price per Share, Forfeited Business Acquisition, Acquiree [Domain] Financial Instrument [Axis] Financial Instrument Research materials shippmet services. Research materials shippmet services [member] Research Materials Shippmet Services [Member] Stock Issued During Period, Value, Stock Options Exercised Exercise of stock options Entity Emerging Growth Company Entity Emerging Growth Company Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period, Intrinsic Value Total intrinsic value of stock options exercised Amendment Flag Amendment Flag Schedule of Accrued Liabilities [Table Text Block] Schedule of Accrued Expenses Marketable Securities, Current Marketable securities Marketable Securities, Current, Total IPO [Member] IPO [Member] Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax Gross Unrealized Losses Accounting Standards Update [Domain] Accounting Standards Update Basis of Accounting, Policy [Policy Text Block] Basis of Presentation Equity Method Investment, Ownership Percentage Equity method investment, ownership percentage Leases [Abstract] Lessee operating lease lease not yet commenced annual base rent per square foot for first year. Lessee Operating Lease Lease Not Yet Commenced Annual Base Rent Per Square Foot For First Year Base rent per square foot for first year Entity File Number Entity File Number Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items] Percentage of Coronavirus Aid Relief and Economic Security Act removes the limit for taxable years. Percentage Of Coronavirus Aid Relief And Economic Security Act Removes Limit For Taxable Years Percentage of Coronavirus Aid Relief and Economic Security Act removes the limit for taxable years Deferred Tax Assets, Gross Gross deferred tax assets Other comprehensive income - unrealized gain (loss) on marketable securities OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax 2016 Employee Stock Purchase Plan [Member] Two Thousand And Sixteen Employee Stock Purchase Plan [Member] 2016 employee stock purchase plan. Share-Based Payment Arrangement [Abstract] Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities Other liabilities assumed Other liabilities assumed Other liabilities assumed Accounts Payable, Current Accounts payable Accounts Payable, Current, Total Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value Weighted Average Grant Date Fair Value per Share, Unvested, Ending balance Weighted Average Grant Date Fair Value per Share, Unvested, Beginning balance Decrease in accounts receivables. Decrease In Accounts Receivables Accounts receivable, Deductions Deferred Tax Assets, Valuation Allowance Deferred tax asset valuation allowance Deferred Tax Assets, Valuation Allowance, Total Costs and Expenses Total operating expenses Investments in and Advances to Affiliates, at Fair Value, Gross Reductions Summary of Transaction Price on Rewrite Merger Agreement Date Determined and Allocated Schedule of Transaction Price Table Text Block Schedule of Transaction Price Table Text Block Finance Lease, Liability, to be Paid, Maturity [Table Text Block] Schedule of Reconciliation of Undiscounted Cash Flows for Operating Lease Liabilities / Future Minimum Lease Payments Auditor Location Expected term (in years) Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term Expected term Collaborative Arrangement [Member] Collaborative Arrangement [Member] Entity Address, Address Line Two Entity Address, Address Line Two Entity Small Business Entity Small Business Entity Shell Company Entity Shell Company Title of Individual [Axis] Number of preferred stock received Sale of Stock, Number of Shares Issued in Transaction Common stock shares sold Remaining transaction price transferred at inception of arrangement. Remaining Transaction Price Transferred At Inception Of Arrangement Remaining transaction price transferred at inception of arrangement Proceeds from Debt, Net of Issuance Costs Net of issuance costs Share-Based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount Unrecognized equity-based compensation expense related to restricted stock Fee to extend collaboration arrangement. Fee To Extend Collaboration Arrangement Fee to extend collaboration arrangement Computer Equipment [Member] Computer Equipment [Member] Area of space leased. Area Of Space Leased Area of space leased Earnings Per Share [Text Block] Loss Per Share Entity Address, Address Line One Entity Address, Address Line One Cash and Cash Equivalents, Fair Value Disclosure Cash equivalents and restricted cash equivalents Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items] Antidilutive Securities [Axis] Antidilutive Securities ONK therapeutics ONK Therapeutics [Member] ONK Therapeutics [Member] Subsequent Event Type [Domain] Probability of achievement Probability of achievement Probability of achievement Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs Stock issuance cost Prepaid Rent Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum Risk-free interest rate, Minimum Income Statement Location [Axis] Income Statement Location 401(k) plan. A401 K Plan [Member] 401(k) plan [Member] Variable Lease, Cost Variable lease cost Regeneron Pharmaceuticals Inc. [Member] Regeneron Pharmaceuticals Inc. Regeneron Pharmaceuticals Inc [Member] Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum Risk-free interest rate , Maximum Deferred Tax Liabilities, Net [Abstract] Deferred tax liabilities: Measurement Input Option, Rate of Return [Member] Measurement Input Option Rate Of Return [Member] Measurement input option rate of return. Non-executive employees. Non-executive Employees [Member] Non-executive Employees [Member] Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate Expected dividend yield Contract with Customer, Liability [Abstract] Contract liabilities: Net Income (Loss), Including Portion Attributable to Noncontrolling Interest Net loss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest, Total Deferred Tax Assets, Deferred Income Deferred revenue 2028 Lessee, Operating Lease, Liability, to be Paid, Year Five Additional target in cap. Additional Target In Cap Additional regeneron target cap Deferred tax assets, tax credit carryforwards, research, expiration description. Deferred Tax Assets Tax Credit Carryforwards Research Expiration Description Research and development tax credits, expiration date description Fair Value, Inputs, Level 2 [Member] Level 2 [Member] Research milestone payments Research milestone payments Research milestone payments Kyverna Therapeutics, Inc. [Member] Kyverna [Member] Kyverna Therapeutics Inc [Member] Kyverna Therapeutics Inc. Equity method investment Equity Method Investments Collaborative Arrangement and Arrangement Other than Collaborative [Table] Schedule Of Collaborative Arrangements And Noncollaborative Arrangement Transactions [Table] Non-Rule 10b5-1 Arrangement Modified NonRule10b51ArrModifiedFlag Non-Rule 10b5-1 Arrangement Modified Two thousand fifteen Plan and Two thousand and sixteen employee stock purchase plan. Two Thousand Fifteen Plan And Two Thousand And Sixteen Employee Stock Purchase Plan [Member] 2015 Plan and the 2016 Employee Stock Purchase Plan [Member] Depreciation, Depletion and Amortization Depreciation and amortization Depreciation and amortization expense Depreciation, Depletion and Amortization, Total Product and Service [Axis] Product and Service Deferred revenue, net of current portion Deferred revenue non-current Contract with Customer, Liability, Noncurrent Title of 12(b) Security Title of 12(b) Security Number of vesting restricted stock units. Number Of Vesting Restricted Stock Units Vesting of restricted stock units, shares Investments and other assets Investments and Other Noncurrent Assets Projected year of achievement Projected year of achievement Projected year of achievement Rewrite Acquisition. Rewrite Acquisition [Member] Rewrite Acquisition [Member] Summary of Financial Assets and Liablilities Recognized at Fair Value on Recurring Basis Fair Value, Assets Measured on Recurring Basis [Table Text Block] Accounting Standards Update [Axis] Accounting Standards Update Quarterly Financial Information Disclosure [Abstract] Other income (expense), net: Other Nonoperating Income (Expense) [Abstract] Prepaid Expenses and Other Current Assets [Member] Prepaid Expense and Other Current Assets [Member] Net Cash Provided by (Used in) Investing Activities [Abstract] CASH FLOWS FROM INVESTING ACTIVITIES: Deferred tax assets, operating loss carryforwards, expiration description. Deferred Tax Assets Operating Loss Carryforwards Expiration Description Net operating loss carryforwards, expiration date description State and Local Jurisdiction [Member] State [Member] Segment Reporting, Policy [Policy Text Block] Segment Information Long-Lived Tangible Asset [Domain] Long-Lived Tangible Asset Share based compensation arrangement by share based payment award equity instruments other than options cancelled in period weighted average grant date fair value. Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Cancelled In Period Weighted Average Grant Date Fair Value Weighted Average Grant Date Fair Value per Share, Cancelled Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block] Restricted Cash Equivalents Contingent Consideration by Type [Axis] Contract with Customer, Liability Deferred revenue, Balance at End of Period Deferred revenue, Balance at Beginning of Period Deferred revenue Contract with Customer, Liability, Total Lessee, Operating Lease, Existence of Option to Terminate [true false] Operating lease, existence of option to terminate Restricted Cash Equivalents, Statement of Financial Position [Extensible Enumeration] Cash and Cash Equivalents [Axis] Defined Contribution Plan, Employer Discretionary Contribution Amount Employer discretionary contribution amount Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term Weighted Average Remaining Contractual Term, Exercisable Common Stock, Shares, Outstanding Ending balance, shares Beginning balance, shares Common stock, shares outstanding Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate Risk-free interest rate Stock-Based Compensation Share-Based Payment Arrangement [Text Block] Non-exclusive license to regeneron under certain Crispr/Cas platform ip. Non Exclusive License To Regeneron Under Certain C R I S P R Cas Platform I P [Member] Non-exclusive License to Regeneron under Certain CRISPR/Cas Platform IP [Member] Business Combinations Policy [Policy Text Block] Asset acquisitions Retirement Plan Type [Axis] Retirement Plan Type Tax Credit Carryforward [Axis] Tax Credit Carryforward Incremental borrowing rate Lessee, Operating Lease, Discount Rate Income Statement Location [Domain] Income Statement Location Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Weighted Average Exercise Price per Share, Granted Document Type Document Type Deferred revenue, net of current portion, related party Contract with customer liability, related party, noncurrent. Contract with Customer Liability, Related Party, Noncurrent Shares issued for Rewrite contingent consideration Shares Issued for Rewrite Contingent Consideration Shares issued for rewrite contingent consideration. Net cash (used in) provided by investing activities Net Cash Provided by (Used in) Investing Activities Marketable Securities, Noncurrent Marketable securities - noncurrent Marketable Securities, Noncurrent, Total Counterparty Name [Domain] Counterparty Name Two thousand nineteen sales agreement. Two Thousand Nineteen Sales Agreement [Member] 2019 Sales Agreement [Member] Lessee, Operating Lease, Option to Terminate Operating lease, option to terminate Capitalized research and development costs Deferred Tax Liabilities, Deferred Expense, Capitalized Research and Development Costs Net Cash Provided by (Used in) Financing Activities Net cash provided by financing activities Entity Filer Category Entity Filer Category Deferred Tax Assets, Tax Credit Carryforwards, Research Research and development credit carryforwards Research and development and other credit Equity-Method Investment and Other Investments Equity Method Investments and Joint Ventures Disclosure [Text Block] Percentage of likelihood of realization needed in order for the company to record a tax benefit. Percentage Likelihood Of Realization Required To Record Tax Benefit Percentage of likelihood of realization required to record tax benefit Balance Sheet Location [Domain] Balance Sheet Location Increase (Decrease) in Accrued Liabilities Accrued expenses Increase (Decrease) in Accrued Liabilities, Total Unrealized gain (loss) on marketable securities Marketable Security, Unrealized Gain (Loss) Marketable Securities, Unrealized Gain (Loss), Total Coronavirus Aid, Relief, and Economic Security Act allows net operating losses carryback period. Coronavirus Aid Relief And Economic Security Act Allows Net Operating Losses Carryback Period Coronavirus Aid Relief and Economic Security Act allows net operating losses carryback period Development milestones Development Milestones [Member] Development milestones [Member] Amount allocated to technology collaboration and research activities. Amount Allocated To Technology Collaboration And Research Activities Amount allocated to technology collaboration and associated research activities Payments to Acquire Marketable Securities Purchases of marketable securities Payments to Acquire Marketable Securities, Total Property plant and equipment estimated useful lives. Property Plant And Equipment Estimated Useful Lives Table [Text Block] Summary of Property and Equipment at Cost and Recognizes Depreciation and Amortization Using the Straight-Line Method Over Estimated Useful Lives Deferred Tax Assets, Tax Credit Carryforwards Tax credit carryforwards, with expiration date Deferred Tax Assets, Tax Credit Carryforwards, Total Performance stock units. Performance Stock Units [Member] PSUs [Member] Capital Expenditures Incurred but Not yet Paid Purchases of property and equipment unpaid at period end Total liabilities Total liabilities Liabilities Property, Plant and Equipment [Table] Schedule Of Property Plant And Equipment [Table] 2020 Stock Purchase Agreement [Member] Two Thousand Twenty Stock Purchase Agreement [Member] Two thousand twenty stock purchase agreement. Equity, Attributable to Parent Ending balance Beginning balance Total stockholders’ equity Cellex and BXLS [Member] Cellex and BXLS [Member] Consolidated Entities [Axis] Documents Incorporated by Reference [Text Block] Documents Incorporated by Reference Net loss Effective Income Tax Rate Reconciliation, Nondeductible Expense, Research and Development, Percent In-process research and development 2015 Stock option and incentive plan. Two Thousand And Fifteen Stock Option And Incentive Plan [Member] 2015 Plan [Member] In-process research and development expense In-Process Research and Development Charge In-process research and development charge Cash and Cash Equivalents [Domain] Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent State income taxes Corporate Debt Securities [Member] Corporate Debt Securities [Member] Fair Value Measurement, Policy [Policy Text Block] Fair Value Measurements Statement of Financial Position [Abstract] Weighted Average Number of Shares Outstanding, Diluted, Total Weighted Average Number of Shares Outstanding, Diluted Weighted average shares outstanding, diluted Weighted average shares outstanding, diluted Non-deductible officers' compensation Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent Schedule of Effective Income Tax Rate Reconciliation [Table Text Block] Schedule of Reconciliation of the Federal Statutory Income Tax Rate and the Company's Effective Income Tax Rate Shares Issued, Price Per Share Common stock price per share Effective Income Tax Rate Reconciliation, Percent Effective income tax rate Commitments And Contingencies [Line Items] Commitments And Contingencies [Line Items] Commitments and contingencies. Deferred tax assets, deferred expense, capitalized start-up. Deferred Tax Assets Deferred Expense Capitalized Startup Capitalized start-up costs Rule 10b5-1 Arrangement Modified Rule10b51ArrModifiedFlag Rule 10b5-1 Arrangement Modified Debt Securities, Available-for-Sale, Amortized Cost Amortized Cost Increase in tenant improvement allowance per rentable square foot Increase in tenant improvement allowance per rentable square foot. Operating Lease, Weighted Average Remaining Lease Term Weighted average remaining lease term Percentage of fair market value of common stock Share-Based Compensation Arrangement by Share-Based Payment Award, Purchase Price of Common Stock, Percent Use of Estimates, Policy [Policy Text Block] Use of Estimates Income Tax Disclosure [Text Block] Income Taxes Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets, Total Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets Other current assets acquired Series A2 Preferred Stock [Member] Series A2 Preferred Stock. Deferred Tax Assets, Net [Abstract] Deferred tax assets: Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price Weighted Average Exercise Price per Share, Outstanding, Ending Balance Weighted Average Exercise Price per Share, Outstanding, Beginning Balance Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Schedule of Basic and Diluted Net Loss Per Share Leasehold Improvements [Member] Leasehold Improvements [Member] Income Tax Authority [Axis] Income Tax Authority Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Fair Value Disclosures [Abstract] Costs and Expenses [Abstract] Operating expenses: Non-cash contribution of intellectual property Non-cash Contribution Of Intellectual Property Non-cash Contribution Of Intellectual Property Non-cash contribution of intellectual property to AvenCell Therapeutics, Inc. Share-Based Compensation Arrangement by Share-Based Payment Award, Percentage of Outstanding Stock Maximum Percentage of cumulative increase in number of shares for future issuance Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy and NAV Main Street 730 Member Main Street 730 Member 730 Main Lease [Member] Measurement Frequency [Domain] Measurement Frequency Caribou Leaseback Agreement [Member] Caribou Leaseback Agreement [Member] Caribou leaseback agreement. Payments to Acquire Property, Plant, and Equipment Purchases of property and equipment Payments to Acquire Property, Plant, and Equipment, Total Disclosure of accounting policy for the contingent payment arrangements including the terms that will result in payment and the accounting treatment that will be followed if such contingencies occur. Contingent Considerations [Policy Text Block] Contingent Consideration Capitalized Contract Cost, Gross Costs to obtain or fulfill contract capitalized Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period Number of shares vested Number of Shares, Vested Number of stock additionally invested Stock Issued During Period, Shares, New Issues Issuance of common stock, shares Employee-related Liabilities, Current Employee compensation and benefits Employee-related Liabilities, Current, Total Business Acquisition [Axis] Total cash, cash equivalents and restricted cash equivalents Cash, cash equivalents and restricted cash equivalents, end of period Cash, cash equivalents and restricted cash equivalents, beginning of period Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations Accounting Standards Update and Change in Accounting Principle [Abstract] Proceeds from Sale and Maturity of Marketable Securities Maturities of marketable securities Proceeds from Sale and Maturity of Marketable Securities, Total Income Tax Disclosure [Abstract] Tax Credit Carryforward, Name [Domain] Tax Credit Carryforward, Name Marketable Securities [Table Text Block] Summary of Available-for-sale Marketable Securities